Géraldine Porcu-Buisson

No ORCID on file · 2 papers in corpus
observational 2025
Frontiers in reproductive health ·doi:10.3389/frph.2025.1650946

BACKGROUND: Around 20% of patients undergoing assisted reproductive technology are at risk of hypo-response to ovarian stimulation. The aim of this study was to describe the real-world use of follitropin delta for ovarian stimulation in the…

guideline 2024
Frontiers in reproductive health ·doi:10.3389/frph.2024.1467322

INTRODUCTION: A Delphi consensus was performed to evaluate expert opinions on the management of key aspects of ovarian stimulation. METHODS: A Scientific Committee developed eleven statements for patient profiles corresponding to predicted…